2014/2759(DEA)
Principles and guidelines of good manufacturing practice for active substances for medicinal products for human use
Basic information
2014/2759(DEA)
DEA - Delegated acts procedure
Supplementing 1999/0134(COD)
Subject
4.20.04 Pharmaceutical products and industry
Status
Procedure completed - delegated act enters into force
Key players
-
European Parliament
Committee responsible Rapporteur Appointed ENVIEnvironment, Public Health and Food Safety
Key events
| Date | Event | Reference | Summary |
|---|---|---|---|
| 28/05/2014 | Non-legislative basic document published | C(2014)03446 | |
| 17/07/2014 | Initial period for examining delegated act 2.0 month(s) | ||
| 16/09/2014 | Initial period for examining delegated act extended at Parliament's request by 2.0 month(s) | ||
| 17/09/2014 | Committee referral announced in Parliament | ||
| 25/11/2014 | Delegated act not objected by Parliament |
Technical information
| Procedure | Information |
|---|---|
| Procedure reference | 2014/2759(DEA) |
| Procedure type | DEA - Delegated acts procedure |
| Nature of procedure | Examination of delegated act |
| Supplementing 1999/0134(COD) | |
| Stage reached in procedure | Procedure completed - delegated act enters into force |
| Committee dossier |
ENVI/8/00856
|
Documentation gateway
-
Document type Reference Date Summary Non-legislative basic document C(2014)03446 28/05/2014 Document attached to the procedure C(2015)4742 06/07/2015 Document attached to the procedure C(2015)6791 05/10/2015